达维塔 DVA
$191.35 −$3.47 (-1.78%)
休市 · Nov 6, 8:10 pm ET · 最新盘后价 $191.35 0.00%
开盘$189.63
昨收$194.82
当日区间$188.75 – $191.90
成交量603.7K
市值$12.04B
市盈率（TTM）14.2
股息率–
DVA 相关新闻
匹配 DaVita 或代码 DVA 的头条新闻，按最新排序。
- DaVita | 4: Statement of changes in beneficial ownership of securities-Officer Maughan David Paul
- BofA Adjusts Price Target on DaVita to $180 From $170
- TD Cowen Upgrades DaVita(DVA.US) to Buy Rating, Raises Target Price to $220 正面
- Truist Financial Maintains DaVita(DVA.US) With Hold Rating, Announces Target Price $215
- Analysts Have Conflicting Sentiments on These Healthcare Companies: Hinge Health, Inc. Class A (HNGE) and DaVita (DVA)
- Deutsche Bank Maintains DaVita(DVA.US) With Buy Rating, Raises Target Price to $265 正面
- Truist Financial Maintains DaVita(DVA.US) With Hold Rating
- BofA Securities Maintains DaVita(DVA.US) With Sell Rating
- Daon Shares (002838): Consolidation synergies drive a sharp earnings surge; DVA commercialization enters the realization phase. 正面
- At US$180, Is DaVita Inc. (NYSE:DVA) Worth Looking At Closely?
- DaVita | 4: Statement of changes in beneficial ownership of securities
- Truist Financial Maintains DaVita(DVA.US) With Hold Rating, Maintains Target Price $215
- Analysts Offer Insights on Healthcare Companies: Hims & Hers Health (HIMS), Lifestance Health Group (LFST) and DaVita (DVA)
- Barclays Maintains DaVita(DVA.US) With Hold Rating, Raises Target Price to $224 正面
- Truist Financial Maintains DaVita(DVA.US) With Hold Rating, Raises Target Price to $250 正面
暂无评论——快来第一个聊聊 DVA。
登录后参与讨论。